Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 10, 2014, Pages 976-983

  Shultz, Sandy R ^a,b   Tan, Xin L ^a   Wright, David K ^a,b   Liu, Shijie J ^a   Semple, Bridgette D ^a,c   Johnston, Leigh ^b   Jones, Nigel C ^a   Cook, Andrew D ^a   Hamilton, John A ^a   O'Brien, Terence J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

animal studies; cytokine; inflammation; models of injury; MRI; traumatic brain injury

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APNEA; ARTICLE; ASTROCYTOSIS; BEHAVIOR DISORDER; BODY TEMPERATURE; BODY WEIGHT; BRAIN ATROPHY; BRAIN DAMAGE; CONTROLLED STUDY; CONVALESCENCE; CORPUS CALLOSUM; GENE INACTIVATION; INJURY SEVERITY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; UNCONSCIOUSNESS; ANIMAL; BRAIN INJURY; C57BL MOUSE; DISEASE MODEL; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84900310858     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3106     Document Type: Article

References (48)

1. Blennow, K., Hardy, J., and Zetterberg, H (2012). The neuropathology and neurobiology of traumatic brain injury. Neuron 76, 886-899
2. Kumar, A., and Loane, D. J. (2012). Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav. Immun. 26, 1191-1201.
3. Johnson, V. E., Stewart, J. E., Begbie, F. D., Trojanowski, J. Q., Smith, D. H., and Stewart, W. (2013). Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136, 28-42
4. Ziebell, J. M., and Morganti-Kossman, M. C. (2010). Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 7. pag 22-30
5. Kadhim, H. J., Duchateau, J., and Sebire, G. (2008). Cytokines and brain injury: invited review. J. Intensive Care Med. 23, 236-249.
6. Laird, M. D., Vender, J. R., and Dhandapani, K. M. (2008). Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16, 154-164
7. Lu, J., Goh, S. J., Tng, P. Y. L., Deng, Y. Y., Ling, E. A., and Moochhala, S. (2009). Systemic inflammatory response following acute traumatic brain injury. Front. Biosci 14, 3795-3813.
8. Masel, B. E., and DeWitt, D. S. (2010). Traumatic brain injury: a disease process, not an event. J. Neurotrauma 27, 1529-1540.
9. Armitage, J. O. (1998). Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 92. pag 4491-4508
10. Metcalf, D. (1989). The molecular control of cell division. pag differentiation commitment and maturation in haemopoietic cells. Nature 339, 27-30
11. Franzen, R., Bouhy, D., and Schoenen, J. (2004). Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor'. Neurosci. Lett. 361, 76-78.
12. McLay, R. N., Kimura, M., Banks, W. A., and Kastin, A. J. (1997). Granulocyte-macrophage colony-stimulating factor crosses the blood- brain and blood-spinal cord barriers. Brain 120, 2083-2091
13. Krieger, M., Both, M., Kranig, S. A., Pitzer, C., Klugmann, M., Vogt, G., Draguhn, A., and Schneider, A. (2012). The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Sci. Rep. 2, 697.
14. Schäbitz, W. R., Krüger, C., Pitzer, C., Weber, D., Laage, R., Gassler, N., Aronowski, J., Mier, W., Kirsch, F., Dittgen, T., Bach, A., Sommer, C., and Schneider, A. (2008). A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 28, 29-43.
15. Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., Arendash, G. W., and Potter, H. (2010). GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J. Alzheimers Dis. 21, 507-518.
16. Mangano, E. N., Peters, S., Litteljohn, D., So, R., Bethune, C., Bobyn, J., Clarke, M., and Hayley, S. (2011). Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease. Neurobiol. Dis. 43, 99-112.
17. Schneider, U. C., Schilling, L., Schroeck, H., Nebe, C. T., Vajkoczy, P., and Woitzik, J. (2007). Granulocyte-macrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion. Stroke 38. 1320-1328
18. Bouhy, D., Malgrange, B., Multon, S., Poirrier, A. L., Scholtes, F., Schoenen, J., and Franzen, R. (2006). Delayed GM-CSF treatment stimulates axonal regeneration and functional recovery in paraplegic rats via an increased BDNF expression by endogenous macrophages. FASEB J. 20, 1239-1241.
19. Ha, Y., Kim, Y. S., Cho, J. M., Yoon, S. H., Park, S. R., Yoon D. H., Kim, E. Y., and Park, H. C. (2005). Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2, 55-61.
20. Hayashi, K., Ohta, S., Kawakami, Y., and Toda, M. (2009). Activation of dendritic-like cells and neural stem/progenitor cells in injured spinal cord by GM-CSF. Neurosci. Res. 64, 96-103.
21. Nishihara, T., Ochi, M., Sugimoto, K., Takahashi, H., Yano, H., Kumon, Y., Ohnishi, T., and Tanaka, J. (2011). Subcutaneous injection containing IL-3 and GM-CSF ameliorates stab wound-induced brain injury in rats. Exp. Neurol. 229, 507-516.
22. Frugier, T., Morganti-Kossmann, M. C., O'Reilly, D., and McLean, C. A. (2010). In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic brain injury. J. Neurotrauma 27, 497-507.
23. Cook, A. D., Braine, E. L., and Hamilton, J. A. (2004). Stimulus-dependent requirement for granulocyte-macrophage colony-stimulating factor in inflammation. J. Immunol. 173, 4643-4651.
24. Hamilton, J. A. (2008). Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8, 533-544.
25. Campbell, I. K., Rich, M. J., Bischof, R. J., Dunn, A. R., Grail, D., and Hamilton, J. A. (1998). Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161, 3639-3644.
26. Alder, J., Fujioka, W., Lifshitz, J., Crockett, D. P., and Thakker-Varia, S. (2011). Lateral fluid percussion: model of traumatic brain injury in mice. J. Vis. Exp. 54, 3063.
27. Carbonell, W. S., Maris, D. O., McCall, T., and Grady, M. S. (1998). Adaptation of the fluid percussion injury model to the mouse. J. Neurotrauma 15, 217-229.
28. Shultz, S. R., MacFabe, D. F., Foley, K. A., Taylor, R., and Cain, D. P. (2012). Sub-concussive brain injury in the Long-Evans rat induces acute neuroinflammation in the absence of behavioral impairments. Behav. Brain Res. 229, 145-152.
29. Spain, A., Daumas, S., Lifshitz, J., Rhodes, J., Andrews, P. J., Horsurgh, K., and Fowler, J. H. (2010). Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury. J. Neurotrauma 27, 1429-1438.
30. Shultz, S. R., MacFabe, D. F., Foley, K. A., Taylor, R., and Cain, D. P. (2011). A single mild fluid percussion injury induces short-term behavioral and neuropathological changes in the Long-Evans rat: support for an animal model of concussion. Behav. Brain Res. 224, 326-335.
31. Conrad, C. D., Galea, L. A. M., Kuroda, Y., and McEwen, B. S. (1996). Chronic stress impairs rat spatial memory on the Y-maze, and this effect is blocked by tianeptine pretreatment. Behav. Neurosci. 110, 1321-1334.
32. Takeuchi, H., Iba, M., Inoue, H., Higuchi, M., Takao, K., Tsukita, K., Karatsu Y, Iwamoto, Y., Miyakawa, T., Suhara, T., Trojanowski, J. Q., Lee, V. M., and Takahashi, R. (2011). P301S mutant tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS One 6, e21050
33. Jones, N. C., Cardamone, L., Williams, J. P., Salzberg, M. R., Myers, D., and O'Brien, T. J. (2008). Experimental traumatic brain injury induces a pervasive hyperanxious phenotype in rats. J. Neurotrauma 25, 1367-1374.
34. Shultz, S. R., Bao, F., Omana, V., Chiu, C., Brown, A., and Cain, D. P. (2012). Repeatedmild lateral fluid percussion brain injury in the rat causes cumulative long-term behavioral impairments, neuroinflammation, and cortical loss in an animal model of repeated concussion. J. Neurotrauma 29, 281-294.
35. Hennig, J., Nauerth, A., and Friedburg, H. (1986). RARE imaging: a fast method for clinical MR. Magn. Reson. Med. 3, 823-833.
36. Liu, Y. R., Cardamone, L., Hogan, R. E., Gregoire, M. C., Williams, J. P., Hicks, R. J., Binns, D., Koe, A., Jones, N. C., Myers D. E., O'Brien, T. J., and Bouilleret, V. (2010). Progressive metabolic and structural cerebral perturbations after traumatic brain injury: an in vivo imaging study in the rat. J. Nucl. Med. 51, 1788-1795.
37. Shultz, S. R., Cardamone, L., Liu, Y. R., Hogan, R. E., Maccotta, L., Wright, D. K., Zheng, P., Koe, A., Gregoire, M. C., Williams, J. P., Hicks, R. J., Jones, N. C., Myers, D. E., O'Brien, T. J., and Bouilleret, V (2013) Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? Epilepsia 54, 1240-1250
38. Shultz, S. R., Bao, F., Weaver, L. C., Cain, D. P., and Brown, A. (2013). Treatment with an anti-CD11d antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion. J. Neuroinflammation 10, 26.
39. Bao, F., Shultz, S. R., Hepburn, J. D., Omana, V., Weaver, L. C., Cain, D. P., and Brown, A. (2012). A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats. J. Neurotrauma 29, 2375-2392.
40. Wahl, S., Barth, H., Ciossek, T., Aktories, K., and Mueller, B. K. (2000). Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 149, 263-270.
41. Bortolato, M., Godar, S. C., Davarian, S., Chen, K., and Shih, J. C (2009). Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34, 2746-2757
42. Kim, E (2002). Agitation aggression, and disinhibition syndromes after traumatic brain injury. NeuroRehabilitation 17, 297-310
43. Guillemin, G., Boussin F. D., Le Grand, R., Croitoru, J., Coffigny, H., and Dormont, D (1996). Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia. 16. pag 71-80
44. Krüger, C., Laage, R., Pitzer, C., Schäbitz, W. R., and Schneider, A. (2007). The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro. BMC Neurosci. 8, 88.
45. Shelbani, N., Grabowski, E. F., Schoenfeld, D. A., and Whalen, M. J. (2004). Effect of granulocyte colony-stimulating factor on functional and histopathological outcome after traumatic brain injury. Crit. Care Med. 32, 2274-2278.
46. Xiong, Y., Lu, D., Qu, C., Goussev, A., Schallert, T., Mahmood, A., and Chopp, M. (2008). Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 109, 510-521.
47. Thyagarajan, T., Totey, S., Danton, M. J., and Kulkarni, A. B. (2003). Genetically altered mouse models: the good, the bad, and the ugly. Crit. Rev. Oral Biol. Med. 14, 154-174.
48. Hamilton, J. A., Davis, J., Pobjoy, J., and Cook, A. D. (2012). GM-CSF is not essential for optimal fertility or for weight control. Cytokine 57, 30-31